Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001064178 | SCV001229060 | pathogenic | not provided | 2023-12-30 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 799 of the ABCA4 protein (p.Pro799Leu). This variant is present in population databases (rs542919944, gnomAD 0.03%). This missense change has been observed in individual(s) with clinical features of inherited retinal dystrophy and/or Stargardt disease (Invitae). ClinVar contains an entry for this variant (Variation ID: 858329). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Ophthalmo- |
RCV002469338 | SCV002765150 | likely pathogenic | Stargardt disease | 2022-12-20 | no assertion criteria provided | research | PM1,PM2,PM3,PP2,PP4 ACMG Criteria |